Home Home > Browse Locations > India

Find Paid Clinical Trials in India

Paid Clinical Trials and Focus Groups


Paid Clinical Trials in India

Top of Directory » All Locations » India


  • Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: NN5401;   Drug: biphasic insulin aspart 30
    Sponsor:   Novo Nordisk
    Recruiting - verified November 2009

  • Effect of Probiotics in Treatment of Minimal Hepatic Encephalopathy (MHE) and Health Related Quality of Life

    Conditions:   Chronic Liver Disease;   Minimal Hepatic Encephalopathy
    Interventions:   Drug: VSL#3;   Drug: Lactulose
    Sponsors:   CD Pharma India Pvt. Ltd.;   Indian Council of Medical Research;   All India Institute of Medical Sciences, New Delhi
    Recruiting - verified November 2009

  • Use of the Modified Atkins Diet in Infantile Spasms

    Condition:   Infantile Spasms
    Intervention:   Other: modified Atkins diet
    Sponsor:   All India Institute of Medical Sciences, New Delhi
    Recruiting - verified November 2009

  • Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: NN1250;   Drug: NN1250;   Drug: insulin glargine
    Sponsor:   Novo Nordisk
    Not yet recruiting - verified September 2009

  • Promoting Evidence-Based Decision-Making in India: District Evaluation Study on Health

    Conditions:   Infectious Disease;   Cardiovascular Disease
    Intervention:   Behavioral: District health information package
    Sponsors:   St. Michael's Hospital, Toronto;   Canadian International Development Agency;   Lombard Insurance Global Poverty Action Lab;   St. John's Research Institute
    Active, not recruiting - verified October 2009

  • TC-5619 as Augmentation Therapy to Improve Cognition in Outpatients With Cognitive Dysfunction in Schizophrenia

    Conditions:   Cognitive Dysfunction;   Schizophrenia
    Interventions:   Drug: TC-5619;   Drug: Placebo
    Sponsor:   Targacept Inc.
    Not yet recruiting - verified October 2009

  • Aripiprazole Open-Label Rollover Study

    Condition:   Schizophrenia
    Intervention:   Drug: Aripiprazole
    Sponsor:   Otsuka Pharmaceutical Development & Commercialization, Inc.
    Active, not recruiting - verified October 2009

  • Comparison of Endoscopic Variceal Ligation (EVL) With Propranolol in Non Cirrhotic Portal Hypertension (NCPH)

    Condition:   Non Cirrhotic Portal Hypertension
    Interventions:   Drug: Propranolol;   Device: multi band ligator for esophageal varices
    Sponsor:   Govind Ballabh Pant Hospital
    Recruiting - verified October 2009

  • Effects of Tamoxifen in Women With Benign Breast Disease Not Having Any Risks for Developing Breast Cancer

    Conditions:   Benign Breast Disease;   Fibrocystic Disease of Breast;   Fibroadenoma;   Mastalgia
    Interventions:   Drug: Tamoxifen;   Drug: Evening Primrose Oil
    Sponsor:   Medical College and Hospital Kolkata
    Completed - verified October 2009

  • Efficacy and Safety of Curcumin Formulation in Alzheimer's Disease

    Condition:   Alzheimer Disease
    Interventions:   Dietary Supplement: Curcumin Formulation;   Dietary Supplement: Placebo
    Sponsors:   Jaslok Hospital and Research Centre;   Pharmanza Herbal Pvt Ltd;   Verdure Sciences;   University of California, Los Angeles
    Recruiting - verified October 2009

  • Mycotic Ulcer Treatment Trial II

    Conditions:   Corneal Ulcer;   Eye Infections, Fungal
    Interventions:   Drug: Voriconazole;   Drug: Placebo
    Sponsors:   University of California, San Francisco;   Aravind Eye Hospitals, India;   Dartmouth-Hitchcock Medical Center
    Not yet recruiting - verified October 2009

  • Mycotic Ulcer Treatment Trial I

    Conditions:   Corneal Ulcer;   Eye Infections, Fungal
    Interventions:   Drug: Natamycin;   Drug: Voriconazole
    Sponsors:   University of California, San Francisco;   Aravind Eye Hospitals, India;   Dartmouth-Hitchcock Medical Center
    Not yet recruiting - verified October 2009

  • Study Evaluating Safety, Tolerability and Efficacy of YM150 in Subjects With Acute Coronary Syndromes

    Condition:   Acute Coronary Syndrome
    Interventions:   Drug: YM150;   Drug: Placebo
    Sponsor:   Astellas Pharma Inc
    Recruiting - verified October 2009

  • Safety and Efficacy of AIN457 in Behçet's Patients With Posterior or Panuveitis

    Condition:   Behcet Disease
    Interventions:   Biological: AIN457;   Biological: AIN457;   Biological: Placebo
    Sponsor:   Novartis Pharmaceuticals
    Recruiting - verified October 2009

    • Menu
    Find Paid Clinical Trials